Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 283-293
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.283
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.283
Ref. | Histology association between histology and disaccharidase activity | Other underlying condition | Sample size, % male | Age range, mean | Ethnicity | Lactase (μmol/min per gram) | Sucrase (μmol/min per gram)mean | Maltase(μmol/min per gram)mean | Palatinase (μmol/min per gram)mean |
Disaccharidase values in iron-deficient infants (1981) Lanzkowsky et al[35] United States | No abnormalities | Severe nutritional iron deficiency anemia | 10 (5 biopsied), sex not reported | 8-30 mo, 14.9 mo | Not reported | Initial: 10 Post-iron treatment: 40 | Initial: 140 Post-iron treatment: 230 | Initial: 190 Post-iron treatment: 400 | Not reported |
Diamine oxidase and disaccharidase activities in small intestinal biopsies of children (1984) Forget et al[24] Belgium | No abnormalities | Bronchitis, vomiting, chronic diarrhea, failure to thrive | 18, 61% | 0.2-6 yr, 2.32 yr | Not reported | 1.78 (measured in U/g wet weight) | 4.34 (measured in U/g wet weight) | 15.48 (measured in U/g wet weight) | Not reported |
Dissacharidase deficiency in children with immunologic deficits (1970) Dubois et al[30] United States | Villous atrophy in two patients with idiopathic acquired hypogammaglobulinemia. No abnormalities in all other patients; Association not reported | Congenital hypogammaglobulinemia; Idiopathic acquired hypogammaglobulinemia; Isolated IgA deficiency; Thymic Dysplasia, Thymic alymphoplasia | 18, 77.80% | 3 mo-16 yr, 8.72 yr | Caucasian | 14.2 (21 biopsies) | 40.1 (20 biopsies) | 150 (20 biopsies) | Not reported |
Histologic findings are not correlated with disaccharidase activities in infants with protracted diarrhea (1991) Shulman et al[5] United States | Mucosal inflammation; No association | Diarrhea of approximately 2 wk, mild to severe malnutrition | 21, sex not reported | 1.0-6.0 mo, 2.5 ± 1.5 mo | Not reported | 17.1 | 71.1 | 224.3 | Not reported |
Intestinal disaccharidase deficiency in children with coeliac disease (1966) Arthur et al[22] United Kingdom | Mucosal inflammation and increased cells in lamina propria; Association not reported | Coeliac disease, post-gastroenteritis, monosaccharide intolerance, and pancreatic hypoplasia | 22, 50% Normal: 6 Celiac disease: 12 Miscellaneous conditions: 4 | 7 mo-10.58 yr, 2.84 yr | Not reported | 3.17 (measured in U/g wet weight) | 3.42 (measured in U/g wet weight) | 9.98 (measured in U/g wet weight) | 1.34 (measured in U/g wet weight) |
Lactose absorption and mucosal disaccharidases in covalescent pellagra and kwashiorkor children (1971) Prinsloo et al[26] South Africa | No abnormalities | Kwashiorkor, classical pellagra without oedema | 22, 68.18% | 15 mo-12 yr, 8.758 yr | Bantu | 5.28 | 50.4 | 173.5 | Not reported |
Intestinal disaccharidase and alkaline phosphatase activity in giadiasis (1984) Welsh et al[7] United States | Villous atrophy in two patients; No association | Giardiasis, diarrhea of 2 wk to 12 mo duration | 23, 43% | 11 mo-14 yr, 3.39 yr | Caucasian | 46 | 82 | 269 | Not reported |
Moderate and severe protein energy malnutrition in childhood: Effects on jejunal mucosal morphology and disaccharidase activites (1983) Römer et al[25] Venezuela | Villous atrophy; Association not reported | Degrees of Malnutrition: I Degree (10%-24% deficit), II Degree (25%-39% deficit), III Degree (over 40% deficit), marasmic kwashiorkor | 33, 60.60% | 0.7-5.6 yr Mean not reported | Not reported | 11.4 | 59 | 191.5 | Not reported |
Disaccharidase activities in jejunal fluid (1983) Aramayo et al[12] United Kingdom | Villous atrophy and parasitic infection; Association present for lactase, sucrase, and maltase | STVA, unspecified gastrointestinal symptoms | 29, sex not reported | 10 mo-14 yr, 5.9 yr | Not reported | 3.67 (measured in U/g wet weight) (approximated from figure) | 6.39 (measured in U/g wet weight) (approximated from figure) | 23 (measured in U/g wet weight) (approximated from figure) | Not reported |
Reinvestigation of lactose intolerant children: lack of correlation between continuing lactose intolerance and small intestinal morphology, disaccharidase activity, and lactose tolerance tests (1977) Harrison et al[8] United Kingdom | Mucosal inflammation and villous atrophy; No association | Secondary lactose intolerance | 30, 69% | 2-38 mo, 10.4 mo | Not reported | 2.3 (data from 4 patients) (measured in U/g wet weight) | 4.4 (data from 4 patients) (measured in U/g wet weight) | 16.4 (data from 4 patients) (measured in U/g wet weight) | Not reported |
Disaccharidases in coeliac disease (1983) Horvath et al[6] Hungary | Villous atrophy; No association | Confirmed and suspected coeliac disease | 30, sex not reported | 8 mo-10 yr, 2.4 yr | Not reported | 2.1 (measured in U/g wet weight) | Not reported | 16 (measured in U/g wet weight) | Not reported |
Quantitative assay of disaccharidase activities of small intestinal mucosal biopsy specimens in infancy and childhood (1965) Townley et al[23] United States | Villous atrophy; Association not reported | Urinary tract infection, cystic fibrosis, diabetes mellitus, hepatosplenomegaly, hypoproteinemia, protein-losing enteropathy, anemia, celiac disease | 36, 58.30% | 1/12-16 11/12 yr, 3.62 yr | Not reported | 1.91 (measured in U/g wet weight) | 3.6 (measured in U/g wet weight) | 13.2 (measured in U/g wet weight) | 4.03 (measured in U/g wet weight) |
Disaccharidase activities in dyspeptic children: Biochemical and molecular investigations of maltase-glucoamylase activity (2002) Karnsakul et al[3] United States | No abnormalities | Dyspepsia, abdominal pain, reflux, vomiting | 44, 66.70% | 0.5-18 yr, 9.5 yr | 37 Caucasian (84%) 1 Hispanic (2%) 2 African (5%) | 7.01 (data from 12 patients) | 19.2 (data from 11 patients) | 92.66 (data from 8 patients) | Not reported |
- Citation: Daileda T, Baek P, Sutter ME, Thakkar K. Disaccharidase activity in children undergoing esophagogastroduodenoscopy: A systematic review. World J Gastrointest Pharmacol Ther 2016; 7(2): 283-293
- URL: https://www.wjgnet.com/2150-5349/full/v7/i2/283.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.283